Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine for Valproate Dose Reduction in Japanese Women with Epilepsy
NCT02100644Phase 4Completed
- Sponsor
- GSK
- Start
- Apr 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamotrigine in epilepsy, sponsored by GSK. Started Apr 2014; status: completed.
02
Drugs
lamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02100644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02100644.